Medications – Es Farmacia Online Mon, 21 Nov 2022 15:27:38 +0000 en-US hourly 1 Medications – Es Farmacia Online 32 32 2021-2030 Forecast Period Overview of the Global Dry Eye Drugs Market Mon, 21 Nov 2022 15:06:00 +0000

Dry Eye Drugs Market 2022 – Opportunities and Strategies – Global Forecast to 2030

The Business Research Company Dry Eye Drugs Market 2022 – Opportunities and Strategies – Global Forecast to 2030

Get 33% off for a limited time on our uniquely designed opportunity and strategy market research reports. Contact us today and develop winning strategies!

— The Business Research Society

LONDON, GREATER LONDON, UK, November 21, 2022 / — Take 33% off for a limited time on our uniquely designed Opportunities and Strategies Market Research Reports. Contact us today and develop winning strategies!

The Business Research Society”Dry Eye Drugs Market Report 2022” forecasts the Dry Eye Drugs Market to grow at a CAGR of 8.2% to reach nearly $4.80 billion by 2025, and at a CAGR of 5.7% to reach 6 .32 billion by 2030.
Promising drugs under development are expected to drive the dry eye market in the future.

Request a sample now to better understand the Dry Eye Drugs Market:

Trends in the dry eye medication market
The development of combination therapies for the treatment of dry eye diseases is an emerging trend in the dry eye drug market. Combination therapy involves the use of more than one drug or drug to treat a disease. These combination therapies reduce the frequency of eye drop or drug administration and reduce the possibility of vascular endothelial growth factor (VEGF) expression, choroidal neovascularization, and inflammation.

Overview of the Dry Eye Drugs Market
The Dry Eye Medications market includes sales of dry eye medications and other related services by entities (organizations, independent traders, and partnerships) that manufacture dry eye medications (or drugs) used to treat eye dryness. The dry eye drugs market covers drugs used in the treatment of diseases related to dry eye, irritation, pain and infection.

To learn more about the Global Dry Eye Drugs Market report, visit:

TBRC Global Dry Eye Drugs Market Report 2021 covers the following insights:
Market segmentation
• By prescription type: over-the-counter drugs, prescription drugs
• By drug variation – brand name, generic
• By product type – aqueous, evaporative, aqueous and evaporative
• By distribution channel: hospital pharmacies, eye health clinics, retail pharmacies, online pharmacies
• By administration system: liquid, gel, ointment, other
• By geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Market Size Data
• Forecast period: historical and future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, United States, South America, Middle East and Africa.
• By country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom, USA.
Major market players such as Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co, Ltd.
Trends, opportunities, strategies and much more.

The Dry Eye Drugs Market Report 2021 is one of the comprehensive reports by The Business Research Company that provides an in-depth study of the Dry Eye Drugs market. The market report gives an analysis of the global Dry Eye Drugs market, forecast market size of the global Dry Eye Drugs market, segments of the global Dry Eye Drugs market, growth drivers of the global dry eye medication market, the growth of the global dry eye medication market across all geographies and the global dry eye medication market. competitors’ revenues and market positioning. The report allows you to gain insights into opportunities and strategies, as well as identify countries and segments with the highest growth potential.

See similar reports from The Business Research Company:

Global Antiglaucoma Drugs Market Report 2022

Global Ophthalmic Drugs Market Report 2022

Global Vision Care Devices and Equipment Market Report 2022

About The business research company?
The Business Research Company has published over 3,000 industry reports covering over 3,000 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Contact us –
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Follow us on:
Health Blog:
Global market model:

Olivier Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Research links diabetes drugs to multiple sclerosis Fri, 18 Nov 2022 18:58:00 +0000

TUCSON, Ariz. – A new study from the University of Arizona Health Sciences has found that people over the age of 45 whose type 2 diabetes is treated with anti-hyperglycemic drugs have an increased risk of multiple sclerosis. plaque, particularly in women, while exposure to anti-hyperglycemics in people under 45 reduces this risk.

“Our findings reinforce the need for a precision medicine approach to preventing MS in these vulnerable populations,” said lead researcher Kathleen Rodgers, PhD, associate director of translational neuroscience at the Center for Innovation in Brain Science.

Multiple sclerosis (MS) is an unpredictable autoimmune neurological disease that affects the central nervous system and leads to severe physical and cognitive disabilities. It is estimated that nearly one million adults in the United States and more than 2.8 million worldwide live with MS.

For people with type 2 diabetes, there is growing evidence linking metabolic disorders and MS through a common factor of increased autoimmunity. This calls into question the impact of anti-hyperglycemic therapies used to treat type 2 diabetes, including insulin, on the incidence of MS.

“Previous research has shown a neuroprotective effect of antihyperglycemic drugs in Alzheimer’s disease and other related dementias,” Dr. Rodgers said. “For MS, we wanted to look in more detail at age and sex differences, particularly in men and women under 45 with type 2 diabetes.”

They found that men over 45 had a slightly significant increased risk of MS and women over 45 had a significantly increased incidence of MS after exposure to anti-hyperglycemics. In addition to age differences, risk analysis by drug class showed that insulin exposure in patients over 45 was associated with a greater increased risk compared to other therapies.

In patients under 45 years of age, exposure to anti-hyperglycaemics protected against the development of MS.

The study used a US-based insurance claims database of 151 million participants to identify more than 5 million patients diagnosed with type 2 diabetes and early or late-onset MS. The researchers segmented the data by age (patients diagnosed with type 2 diabetes before or after age 45) and by sex to decode risk factors for MS in both populations, particularly among women over age 45.

The article, “Age and sex differences in antihyperglycemic drug exposure and risk of newly diagnosed multiple sclerosis in propensity score-matched type 2 diabetics,” was recently published in the Heliyon magazine.

Co-authors from the Center for Innovation in Brian Science include Roberta Diaz Brinton, PhD, Director and Regents Professor; Francesca Vitali, PhD, assistant research professor of neurology; Georgina Torrandell-Haro, PhD student and graduate research assistant; and Gregory Branigan, PhD, a third-year medical student at the UArizona College of Medicine – MD-PhD program in Tucson.

This research was supported in part by the National Institute on Aging (P01AG026572, T32AG061897, R37AG053589) and the National Institute of Neurological Disorders and Stroke (R25NS107185), two divisions of the National Institutes of Health.

/Public release. This material from the original organization/authors may be ad hoc in nature, edited for clarity, style and length. The views and opinions expressed are those of the author or authors.View Full here.

6 types of prescription drugs that affect driving Tue, 15 Nov 2022 19:51:34 +0000

Some antihistamines also cause mental confusion, blurred vision, and reduced ability to concentrate.

In today’s fast-paced world, most people spend at least an hour a day commuting to work, school, or other activities. As a result, many people choose to drive instead of walking, cycling or taking public transport. However, some people need to take medication to treat specific medical conditions.

These prescription drugs can have adverse side effects on driving performance, making it unsafe to operate a motor vehicle unless another adult is aware of the risks and agrees to be their designated driver. Also, some medications may not be safe to take and drive because they impair judgment or reaction time while driving.

1. Painkillers

Painkillers are a common prescription drug. However, painkillers can impact driving performance if they impair the driver’s ability to concentrate on the road. They can also cause drowsiness, dizziness and blurred vision and can interfere with concentration and attention.

Most painkillers are not illegal to take while driving, but some drugs can make driving a motor vehicle dangerous for the driver. For example, some painkillers can cause drowsiness or impair driving performance.

2. Stimulants

Stimulants treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and sleep apnea. If a person is taking stimulants, they should not drive until the effects of the drug have worn off. Long-acting stimulants can also impair driving performance and should not be taken while driving.

Stimulants, such as amphetamines and cocaine, can impair a driver’s judgment and reaction time. This can lead to dangerous driving conditions, such as driving too fast or failing to stop at a stop sign or traffic light.

If you or your loved one were involved in a car accident because of prescribed medication, you could be charged with driving under the influence. If you are convicted of driving under the influence, you will face severe penalties, including fines and jail time. A prescription drug DUI lawyer can help you fight the charges against you.

3. Antihistamines

Antihistamines are used to treat allergies and colds. These drugs can cause drowsiness, fatigue, and dizziness. Some antihistamines also cause mental confusion, blurred vision, and reduced ability to concentrate.

Because these drugs can make driving a vehicle dangerous for the person taking them, many states have banned their use during driving hours or while driving on the road. For example, in many states you cannot take an antihistamine within 6 hours of driving.

4. Antidepressants

Antidepressants treat depression or anxiety due to personal problems or work stress. Antidepressants can make the person taking them drive a car dangerous because they impair judgment and reaction time while driving.

Some antidepressants can also cause drowsiness, dizziness, fatigue, and blurred vision while driving and can impair concentration and attention. Some antidepressants are known to cause mental confusion and reduced ability to concentrate.

5. Antihypertensives

Antihypertensives are a class of drugs that treat high blood pressure and other conditions related to high blood pressure. Antihypertensives can cause drowsiness and impair the ability to concentrate or react while driving. For example, beta-blockers are prescribed to help treat high blood pressure.

Although beta-blockers do not affect driving performance, they can cause drowsiness, dizziness and blurred vision. Beta-blockers can also make driving a motor vehicle dangerous for the driver, as they can reduce reaction time and maintain concentration.

Antihypertensives can also cause an increased risk of stroke and heart attack. Therefore, people with these chronic conditions should consult their doctor to find out if it is safe to drive while taking antihypertensive medications.

6. Muscle relaxants

Tired driver; image by Johan Funke, via

Muscle relaxants are used to treat muscle spasms, cramps, and tension. Although these are generally considered safe to take as prescribed, some people who take them may experience drowsiness or confusion while driving. This is because muscle relaxants can reduce muscle activity and slow down the brain.

Additionally, since muscle relaxants also slow the heart rate, they can cause irregular heartbeats or low blood pressure, which further slows down the brain and makes it difficult for a person to react quickly to unexpected situations that may arise while driving. .

Find a legal advisor

If you have been charged with a DUI after taking a prescription drug, contact an attorney. They can help protect your rights during legal proceedings and represent your best interests. Your attorney will plan a solid defense strategy to fight the charges against you.

Many law firms offer a free initial review of the file during which a lawyer will explain the main legal steps to take. If you feel comfortable with the legal expert, you can continue to work with him.

]]> New South Wales pharmacists will prescribe pills and antibiotics and repeat scripts during major health system changes Sat, 12 Nov 2022 23:23:54 +0000

Huge changes in chemists and pharmacists start prescribing hundreds of drugs to relieve overwhelmed GPs

  • With a shortage of doctors, a state will allow pharmacists to prescribe drugs
  • The public will be able to obtain private consultations with a pharmacist, for a fee
  • A state premier says the federal government should do more to help

Pharmacists will soon be allowed to prescribe hundreds of drugs to relieve pressure on overwhelmed GP clinics.

With a growing shortage of GPs in Australia, pharmacists in NSW will be able to prescribe antibiotics, birth control pills and refill prescriptions.

Pharmacies will also administer more public health and travel vaccinations when the program begins on Monday.

Under future NSW government plans, the public will be allowed to get a private consultation with a pharmacist – costing $20 to $30 – who can then prescribe medication.

Prime Minister Dominic Perrottet said the federal government should provide more support for GPs and more free bulk billing services.

Pharmacists will soon be able to prescribe certain drugs. Pictured is a pharmacist talking to a customer

“We can’t sit back and wait for them to catch up and meet the growing demand,” he said..

The second stage will be a year-long trial where pharmacists will be allowed to prescribe drugs for conditions such as urinary tract infections.

The third stage would involve a pilot program across NSW where pharmacists could prescribe drugs for conditions such as gastro, allergies, shingles and acne.

Mr Perrottet said giving the community better access to medicines and vaccines through pharmacies would reduce pressure on GPs.

NSW Health Minister Brad Hazzard said the trials would be similar to changes in medical care in Queensland and would be open to pharmacists after undergoing additional training.

“The positive contribution (of pharmacists) to the management of the Covid-19 pandemic has demonstrated that they are able to do more for their communities,” he said.

Mr Hazzard said NSW Health would ensure high safety standards were maintained.

Minister for Women, Regional Health and Mental Health Bronnie Taylor said the NSW changes will transform healthcare in the regions, especially for women.

“Pharmacies are part of the fabric of our regional communities and empowering our trusted pharmacists to perform their full scope of practice will be a game changer for so many people,” she said.

There will be a $20 to $30 fee to get a private consultation with a pharmacist.  In the photo, a pharmacist chooses prescription drugs

There will be a $20 to $30 fee to get a private consultation with a pharmacist. In the photo, a pharmacist chooses prescription drugs

“The NSW Government has heard loud and clear that the process of getting a script for things like a urinary tract infection or birth control needs to be made easier. This reform takes this into account and lightens the burden on our general practitioners.

NSW Health will work with pharmacists to support the expansion of the vaccination program with educational modules and materials for themselves and their customers.

Pharmacists in NSW are currently able to administer six vaccines, including for Covid-19 and flu.

Expressions of interest for participation in the urinary tract infection trial open on Monday, with the trial starting in February.

The Royal Australian College of General Practitioners (RACGP) called NSW’s move ‘madness’ and a ‘recipe for disaster’.

“This is not a solution for patients, this is a solution for the pharmacy lobby,” said RACGP President Karen Price.


Doctor acquitted of rape faces suspension for overprescribing drugs and inappropriate patient records Thu, 10 Nov 2022 04:28:00 +0000

SINGAPORE: A doctor who was acquitted of rape and sexual assault after a high-profile trial, he now faces a suspension for improperly prescribing medication and failing to keep adequate patient medical records.

Dr Wee Teong Boo, 71, pleaded guilty in a disciplinary court to 10 counts of improperly prescribing cough mixtures and benzodiazepines – a type of depressants used to treat conditions such as anxiety and depression. ‘insomnia. He also admitted 10 counts of poor record keeping.

This case stems from a 2016 complaint that the Singapore Medical Council (SMC) received from the Ministry of Health, which raised concerns about Dr Wee’s practices in prescribing benzodiazepines and cough mixtures containing codeine.

The court imposed a 20-month suspension on Dr Wee, but the SMC appealed on Thursday November 10 for a longer suspension period of 30 to 36 months.

Acting on behalf of the SMC, attorney Edmund Kronenburg of Braddell Brothers told the Tri-Judge Court that the Disciplinary Tribunal erred in accepting that Dr Wee was not motivated by financial gain.

On the charges of improper record keeping, Mr Kronenburg said Dr Wee’s notes were “largely unreadable”.

He did not take any form of sensible notes for the patients in question, the lawyer said, adding that the SMC could not say what medical conditions the patients actually had.

Pointing to the notes written for different patients, the lawyer said that for patient 1 only the word “cough” was written. For another patient, there was “no reasonable documentation”, while another patient only had the word “anxiety” labeled.

Chief Justice Sundaresh Menon, who heard the appeal with Justices Steven Chong and Judith Prakash, said Dr Wee was clearly not giving the drugs away for free.

“There would be an element of profit. The idea that there was no financial incentive behind it – I find it hard to understand,” he said.

Chief Justice Menon asked Mr. Kronenburg why SMC was not seeking an expungement order for Dr. Wee, since SMC’s case was that he had prescribed the drugs to people he knew to be drug addicts.

He said Dr Wee’s explanation when he was first confronted with the case suggested he gave the drugs to manage the patients’ addictions.

“Is this an acceptable thing to do?” asked the Chief Justice. “Because if it’s okay for a doctor to prescribe addictive drugs to feed or manage an addiction, then I would find that surprising.”

Mr. Kronenburg explained that the actual loads relate to exceeding what was prescribed under the guidelines. The charges were not aimed at calling Dr. Wee a trafficker prescribing drugs when he had no reason to do so.

He admitted that the fact that Dr Wee was prescribing drugs to drug addicts came to light during the disciplinary court investigation.

“He saw himself as an alternative to street traffickers,” Chief Justice Menon said. “Just looking at this document (which says this) is fundamentally disturbing. It has nothing to do with exceeding prescribed limits. The reason he exceeded prescribed limits was not because the patient had a bad cough was because he was feeding their addiction.”

The court requested additional submissions from SMC’s attorneys and Dr. Wee’s attorney, Mr. Chooi Jing Yen. The case was adjourned to a later date.

UHS offers many resources for diabetes care Sun, 06 Nov 2022 23:03:22 +0000

Diabetes is a chronic, progressive disease that you will have to manage independently on a daily basis for the rest of your life. Although it may seem overwhelming, with the help of the team at UHS Diabetes Center, it is not obligated. Located at 93 Pennsylvania Ave. in Binghamton, the Diabetes Center has served the area since the 1970s. The center manages care for patients with type 1, type 2, and gestational diabetes ages 18 and older, whether newly diagnosed or that they have had diabetes for many years.

November is National Diabetes Month.

UHS Registered Dietitians and Certified Diabetes Educators note, “Diabetes affects most activities of daily living. However, diabetes doesn’t have to limit your dreams or ambitions: with a little planning, a person with diabetes can do anything. We help patients learn techniques to self-manage their illness by monitoring their blood sugar, eating healthy, being active, taking medication, managing stress, and prioritizing self-care to prevent or delay heart attacks. complications of diabetes.

Diabetes can affect people of all ages. Diagnosis usually occurs when an individual experiences symptoms such as blurred vision, increased thirst and urination, fatigue, hunger, drowsiness, slow-healing cuts or sores, or numbness or tingling in the feet, prompting a provider to order a blood test. Adults 45 and older should be screened regularly for diabetes. It’s important to get tested for diabetes regularly with your primary care provider, even if you don’t have any symptoms, because many people don’t realize they have high blood sugar.

The Diabetes Center team includes endocrinologists, nurse practitioners, diabetes educators and a dietitian. For diabetes-related foot, eye, dental, or mental health care, patients can be referred directly to specialists at UHS. The team creates an individualized treatment plan based on each patient’s specific needs, barriers, and personal circumstances. Routine visits with the endocrinologist or nurse practitioner are scheduled every three to four months, and between appointments patients can call with questions or concerns. Direct connections with each patient’s primary care provider ensure that everyone involved in the patient’s care is on the same page.

UHS experts say the disease process is always changing, and factors such as stress, pain, food, physical activity, illness, sleep and medications can affect blood sugar levels. Communication is key between the patient and the diabetes team, whether it’s reporting blood sugar levels, discussing a problem, or talking about more affordable medications or treatments. UHS’ unique approach means patients can access comprehensive diabetes management and diabetes education under one roof.

Recent advances in diabetes care technology mean that patients now have more options than ever to manage the disease:

  • A CGM is a small sensor worn on the abdomen or the back of the arm – it provides a blood sugar reading without a finger prick (not all insurance plans cover this, so be sure to check from your operator). Many continuous glucose monitors send blood glucose readings directly to a smartphone or receiver.
  • Insulin pumps can help increase the amount of time a person’s blood sugar is in range with advanced features like stopping insulin delivery or increasing insulin delivery to from sensor readings or increasing insulin based on glucose readings.
  • New blood glucose meters consume less blood and connect to smartphone apps.
  • Improved insulin pens make injections easier and easy to get concentrated insulin. New oral and injectable medications are now available, providing more treatment options for patients with type 2 diabetes.
  • Diabetes websites and apps help patients monitor and track their progress, provide increased resources for education, and engage patients in self-care.

For more information on UHS Diabetes Services, Click here.

Detainee abused prescription drugs, inquest says Wed, 02 Nov 2022 23:11:51 +0000

Lisa Waddell, who was the prison’s acting deputy warden at the time, testified on December 10, 2019 McKenzie was admitted to prison after being arrested for violating his release conditions by failing a drug test drug. He had been released from the mental center about three months earlier.

Waddell explained that Correctional Service Canada policy dictates that an inmate is first received by the prison, and then a referral will come next for transfer. He was then asked if there had ever been a case where discretion had been used otherwise.

“I’ve never heard of that,” she said.

Waddell also confirmed that she knew McKenzie’s transfer to the psychiatric center began on February 25, the same day McKenzie mutilated his nose and was ultimately sent to Prince Albert Hospital for treatment.

In the past two days, there was a lot of discussion regarding McKenzie’s long history of self-harm.

Holly Osecki, nurse practitioner in Saskatchewan. Pen, saw McKenzie on February 5, 2020 and treated McKenzie for multiple lacerations to his chest, forearms and abdomen. McKenzie received nearly 20 stitches.

“I haven’t seen anything graphic as to a reason,” she said when asked what the reason for the self-harm was.

Commenting on the fact that McKenzie’s mental health had not improved since returning to prison, Osecki said she did not know why he was fired from the CPP.

When asked what she would do to help prevent similar deaths in the future, she explained that there was no simple answer and that the manpower and resources available had to be considered. .

“We’re all doing our best,” she said.

Osecki said his ideal would be a mental health unit at the prison that would be staffed around the clock with nurses and mental health workers.

Ashley Kuzma, an occupational therapist at the prison, had a number of direct interactions with McKenzie through programs such as cooking classes or recreational activities such as volleyball. Earlier this week, McKenzie was described as a quiet, shy guy who was embarrassed by his nose.

“He was always involved,” Kuzma said, adding that McKenzie, who also loved to draw, was always engaged and happy when interacting with others.

Following McKenzie’s self-harm incident on February 5, Kuzma said instructions were given for increased surveillance and a plan was discussed with McKenzie regarding a razor swap and the removal of sheets from his cell door. McKenzie also received a pocket radio, something he identified as a coping tool due to his love of music, Kuzma said.

Regarding why McKenzie cut himself on Feb. 5, Kuzma said he revealed to her that he felt anxious about an upcoming court hearing and the recent discontinuation of some antidepressant medications. that he had taken while he was in the community.

Two days after the incident, McKenzie was returned to his firing range. Kuzma confirmed that he confided in her that he was having dark thoughts and had considered asking to be taken to an observation cell.

However, McKenzie ultimately decided against it, explaining to Kuzma that returning to the lineup would be more beneficial as he had access to support, and said recent coping mechanisms he had learned were working.

A man who was not originally on the witness list, but who contacted the investigation, also testified on Wednesday, saying he had valuable information to provide.

Shane Pattison, detained in Sask. Pen, had lived on the same beach as McKenzie for nearly two years, and the two often hung out together to play cards. Pattison described McKenzie as easy-going, who didn’t pick on anyone.

“He had his own struggles,” Pattison said, adding that his friend often talked about his medications not working or being rejected by mental health workers.

The reason McKenzie’s meds were discontinued on Feb. 5, 2020 had yet to be provided for the inquest, but Pattison revealed his friend “played” them every day.

“He offered to snort them with him,” he said.

Thinking back to the day McKenzie returned to the shooting range, a day after cutting his nose, Pattison said he was surprised to see his friend return so soon, adding that he didn’t feel ready. Even McKenzie’s own assurances that he was doing good pleased Pattison.

“It looked like he was ready to give up,” he said.

Pattison then recalled how McKenzie later asked if the guards had done their rounds yet, to which Pattison replied that they had.

“He went quiet and all you could hear was the sheets ripping,” Pattison described, adding that at first all he thought was his friend setting up a screen. privacy. Moments later, Pattison and others saw McKenzie hanging and immediately called for help.

Presiding coroner Tim Hawryluk called Pattison’s testimony, particularly prescription drug abuse, critical evidence.

‘There seems to be a significant blind spot there,’ he said and asked Joele Fiddler, who was in charge of prison health care at the time of McKenzie’s death, to respond. .

“Yeah, that’s a surprise,” she said.

Fiddler was then asked by Hawryluk about the changes from prescription drugs she would be making, and she mentioned a number of possibilities, including having a corrections officer in the hallway, constant mouth checking and waiting times for medications.

“You can’t take everyone off the drug,” she said.

Fiddler also testified that McKenzie had seen a psychiatrist at least eight times and a psychologist about three times. She added that the recruitment of medical professionals in the prison is very difficult and there is often a vacancy when it comes to psychologists.

A total of 27 witnesses have been programmed for this week’s survey and the last are expected on Thursday.

Afterwards, the jury will be sequestered and asked to compile a list of recommendations that they believe would help prevent similar deaths from occurring in the future.

If you or someone you know is in immediate danger of self-harm or has suicidal thoughts, please contact:

Canadian Suicide Prevention Service (1-833-456-4566), Saskatoon Crisis Intervention Service (306-933-6200), Prince Albert Mobile Crisis Unit (306-764-1011), Regina Mobile Crisis Services (306-525- 5333) or the Hope for Wellness Helpline, which offers culturally appropriate crisis response support for Indigenous people at (1-855-242-3310).

On Twitter: @nigelmaxwell

]]> Miracle Diabetes Curing Diet Nets Biggest Deal in Shark Tank History! Thu, 27 Oct 2022 11:35:31 +0000

() – It was the most watched episode in Shark Tank history when sisters Anna and Samantha Martin won the Shark Tank panel

Anna and Samantha Martin, sisters and chemists from MIT, landed the biggest deal in Shark Tank history as the 6 Sharks teamed up to launch the company with a staggering $2.5 million! In just 6 months, their product has completely disrupted the diabetes industry in the United States, and with the help of the Sharks, they are now ready to take on the global market.

After a complete brand overhaul and repackaging, the sisters are now ready to launch their new brand, StrictionD advanced formula. Watch the incredible demonstration below that prepared the sharks to feed instantly!

Apparently, the Kim sisters have invented a new chemical compound that can lower blood sugar and lower bad cholesterol. More important again, it can effectively reverse high blood sugar.

Although there are a number of “supplements” on the market that claim to cure diabetes, the Kim sisters created the first reuptake inhibitor (RI), which makes it particularly more effective in permanently reducing blood sugar.

The judges were amazed that one product was able to do all of the following:

– Regulates blood pressure

– Balances blood sugar levels

– Lowers bad cholesterol (LDL)

– Increases good cholesterol (HDL)

– Reverses insulin resistance

– Made from 100% natural and organic ingredients

RI works by blocking inhibition of the plasmalemmal transporter-mediated reuptake of a neurotransmitter from the synapse into the pre-synaptic neuron. What this means for men without a PhD in chemistry: a permanent cure for diabetes.

The sisters were the first candidates in Shark Tank history to receive investment offers from all six panel members.

The diabetes industry is a huge market, but it is rarely reported. Studies have shown that 32% of American adults have high blood sugar and only about 54% of people with high blood sugar have their condition under control.

In order to test the validity of sister Kim’s product, Shark Tank decided to take on a volunteer among its production teams. Meet Kathy Rhodes, a 54-year-old mother of 3 who jumped at the chance to test StrictionD advanced formula.

Kathy is a 54 year old professional who had clinical hypertension for over 13 years. We had to wait 2 weeks to get a bottle to test as it was sold out almost everywhere we looked. We asked her to track her progress for the 14-day test.

What were the results ?

Day 1 :“I took two StrictionD Advanced Formula softgels and forgot all about them. About 1-2 hours later I started to feel strangely better. I can only describe it by saying that somehow it was easier to breathe. I was walking inside a mall and usually I would have been a bit dizzy with a headache, and also felt nauseous at the time, but I was totally fine . For a moment, I felt like my high blood sugar was completely normal. It was a feeling of hope and I got really curious what was going to happen next – it was awesome.”

Day 5:“Over the next 5 days I started to feel better and better! I found myself bouncing out of bed and feeling ready to take on the day – usually I have to hit the snooze button at minus twice. I felt motivation like I hadn’t felt in years. I had consistently higher energy levels, rather than the ups and downs I was used to. I was also able to sleep through the night!I was shocked at the drastic results.

Day 14:“After 14 days, not only were all my doubts and skepticism completely gone – my high blood sugar was completely normal and I no longer needed to check it 10 times a day. I had no idea about two secret ingredients little known in a natural supplement could make a big positive difference in how I felt I am very grateful to Shark Tank for sharing their findings with us and giving StrictionD Advanced Formula A try!”

What talk show host Oprah Winfrey has to say about StrictionD Advanced Formula!

Oprah suffers from high blood sugar due to her unhealthy lifestyle. She linked this to her excess salt intake. Oprah uses StrictionD Advanced Formula for the last 5 months.

“The pills arrived much faster than expected. I was eager to see if StrictionD Advanced Formula Lived up to the hype. I took a pill every night before bed. In less than 6 days, my blood sugar returned to the stable range for the first time in years.” – Oprah Winfrey.

Will StrictionD Advanced Formula work for you?

There are many remedies for high blood sugar that you can try. Some of them include taking drugs with dangerous side effects. Others involve putting needles into your body. With so many options, it’s normal to be skeptical about the results. So instead of promising our readers anything, we challenge you to follow in Oprah’s footsteps and try it yourself!

The Sharks said the pills were designed to lower blood sugar, and that’s exactly what happened to Oprah. When contacted for comment, The Sharks graciously provided our readers with their promotional package: special bottles + FREE delivery of StrictionD Advanced Formula! You can find these links below.

Remember that it is important that you use the to get the full healing results.

This SPECIAL offer won’t last long, so be sure to follow the link below and save up your BENEFITS today before it runs out!


“If there was ever a ‘miracle pill’ it was this one. After the first week I started noticing that my blood sugar readings were starting to drop. StrictionD Advanced Formula not only helped me lower my blood sugar, but it also made me feel energized and sleep better! I started taking StrictionD Advanced Formula about a month ago and I haven’t felt this good in a long time.”

Before taking them, I always felt fatigue and pain in my chest. These pills are excellent and easy to take without any side effects.”

Lacey Brown,

“I decided to try StrictionD Advanced Formula just out of curiosity and because they offered special bottles so nothing to lose. I didn’t believe that some pills other than Vasotec or Prinivil could lower blood sugar.

After you got my bottle, you might not believe my high blood sugar was completely cured.”

Andrea Taylor,
Golden Coast

“My blood sugar and blood pressure are now in the normal range, and my husband is happy for me,

Kelly Smith,
Melbourne CBD

Special offer

Step 1:

The special offer is limited.
Expired :

Digital nomadism could be the perfect self-medication for your 9-5 burnout Sun, 23 Oct 2022 16:37:48 +0000

What was once a common way of life before food was readily available in every city block, nomadism starts to rise again. This lifestyle that requires constant movement becomes the perfect the solution for those who find themselves restless in a constant environment.

Many who have embraced the digital nomad lifestyle have noticed how the constant change of scenery, people, and culture stimulates their brains and allows them to work at the peak of their abilities. As more studies are conducted on this group of digital nomads, one obvious attribute has emerged.

Neurodivergence is a common thread among nomads working the digital lifestyle. For those unfamiliar, this term refers to those whose brains function differently from what is considered “typical” in society. Neurodivergence encompasses people with ADHD and ASD.

Those diagnosed with ADHD are known to be forgetful, have difficulty concentrating, and be very impulsive. Digital nomadism has become a form of self-medication for many people with ADHD. They are exposed to new surroundings, new people, new adventures, and there is always something going on in their lives.

Psychologist Sonia Jaeger chimed in on the topic, stating that a large portion of the digital nomad community is made up of neurodivergent individuals. This lifestyle is seen as a positive way for people with neurodivergence to quell their need for constant change and lead mentally fulfilling lives.

In recent pandemic years, digital nomadism has exploded as more and more job opportunities slip away. Most of those who experience this lifestyle work in the industries of software development, website design and development, copywriting, and graphic design.

]]> Planned Parenthood asks North Carolina court to allow non-physicians to provide medical abortion to meet out-of-state demand Wed, 19 Oct 2022 00:51:41 +0000

Abortion restrictions in the South are leading to an overburdened system and delaying access to abortion in states where abortion is legal, according to a court case in North Carolina this week.

Medical professionals asked a state court to to block a ban that stop physician assistants, nurse practitioners, and certified nurse midwives, known as advanced practice clinicians, to perform medical abortions. If allowed, more people would be able to access abortion services instead of facing an ‘insurmountable barrier’, according to SisterSong Women of Color Reproductive Justice Collectivewho filed the petition with Planned Parenthood South Atlantic.

“The ban on qualified advanced practice clinicians from performing medical abortion is completely arbitrary, medically unnecessary, and profoundly limits access to abortion in North Carolina,” said Anne Logan Bass, nurse practitioner at Planned Parenthood South Atlantic in a Press release.

Monday’s motion against the speaker of the North Carolina House of Representatives is part of a 2020 lawsuit challenging several restrictions on abortion providers, but the motion specifically seeks temporary approval for APC provide abortion services while the trial is ongoing.

Planned Parenthood claimed that since the Dobbs decision, more patients from neighboring states that have banned abortions flocked to North Carolina to seek abortions, leading to longer delays in accessing abortions.

According to the motion, more than a third of patients who had abortions at Planned Parenthood South Atlantic between July 1 and September 30 were from out of state, totaling 1,317 people. During the same period last year, only 322 patients came from out of state for abortions.

In North Carolina, abortion is legal until 20 weeks of pregnancy.

“Let’s be clear: Abortion is still legal in North Carolina, but a politically motivated abortion restriction has created an insurmountable barrier for too many pregnant women in the state and region. said Monica Simpson, executive director of SisterSong Women of Color Reproductive Justice Collective.

Medical abortion involves a combination of drugs – mifepristone and misoprostol – in pill form within a specified time frame. Although APCs are currently allowed to prescribe the drugs for miscarriage, they are prohibited from prescribing them for abortion, known as the “APC ban”.

“This, in turn, has exacerbated the long wait times experienced by North Carolinas seeking abortions, forcing them to remain pregnant against their will for longer periods of time, potentially pushing them over the edge of gestational age for medical abortion, and more,” Planned Parenthood said in the motion.

In one North Carolina city, Asheville, wait times for medical abortion appointments have dropped from 12 days in July, August and September 2021 to 21 days since July 1 of this year.

The agencies filing the petition say the “APC ban” violates the state’s Equal Protection Clause because it discriminates on the basis of sex and treats patients who wish to terminate their pregnancies differently from those who want to carry their pregnancy to term.

A spokesperson for the North Carolina House of Representatives did not immediately respond to a request for comment.

It remains to be seen whether the judge will approve the motion for a temporary injunction and allow CPAs to provide medical abortion. A trial is scheduled in the original case for September 2023.

Photo: ericsphotography, Getty Images